Johannes F Fahrmann Selected Research

Johannes F Fahrmann Research Topics

Disease

36	Neoplasms (Cancer) 11/2023 - 03/2013
9	Adenocarcinoma of Lung 02/2024 - 11/2015
9	Adenocarcinoma 01/2022 - 05/2015
8	Lung Neoplasms (Lung Cancer) 01/2023 - 11/2015
6	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 01/2019
5	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2020
4	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2020
3	Disease Progression 11/2023 - 01/2020
3	Triple Negative Breast Neoplasms 01/2022 - 01/2020
2	Inflammation (Inflammations) 11/2023 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 01/2020
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 11/2020 - 01/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024
1	Colorectal Neoplasms (Colorectal Cancer) 11/2023
1	Obesity 11/2023
1	Genomic Instability 11/2023
1	Bites and Stings (Sting) 11/2023
1	Acute Coronary Syndrome 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2022
1	Leukemia 08/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 08/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2022
1	Residual Neoplasm 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2021

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2016
15	Biomarkers (Surrogate Marker)IBA 02/2024 - 11/2015
8	PolyaminesIBA 01/2023 - 01/2017
5	AntigensIBA 10/2022 - 01/2020
5	LipidsIBA 01/2020 - 01/2015
3	EnzymesIBA 01/2023 - 05/2022
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2020
3	AutoantibodiesIBA 08/2022 - 01/2020
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 01/2013
3	ProteomeIBA 05/2020 - 01/2016
3	Neoplasm Antigens (Tumor Antigens)IBA 02/2020 - 01/2020
2	Chimeric Antigen ReceptorsIBA 01/2024 - 11/2022
2	CeramidesIBA 08/2023 - 01/2020
2	kynureninaseIBA 01/2023 - 05/2022
2	Tryptophan (L-Tryptophan)FDA Link 01/2023 - 05/2022
2	KynurenineIBA 01/2023 - 05/2022
2	N',N''-diacetylspermineIBA 11/2022 - 01/2020
2	Keratin-19 (Keratin 19)IBA 10/2022 - 08/2022
2	Surface-Active Agents (Surfactants)IBA 10/2022 - 08/2022
2	IgA receptor (protein B)IBA 10/2022 - 08/2022
2	Carcinoembryonic AntigenIBA 10/2022 - 08/2022
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 11/2020
2	AntioxidantsIBA 01/2016 - 05/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2015 - 03/2013
1	Circulating MicroRNAIBA 02/2024
1	Cell-Free Nucleic AcidsIBA 12/2023
1	PrebioticsIBA 11/2023
1	Androgen Receptors (Androgen Receptor)IBA 11/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2023
1	Galactosylceramides (Galactocerebrosides)IBA 08/2023
1	Sulfoglycosphingolipids (Sulfatides)IBA 08/2023
1	Kelch-Like ECH-Associated Protein 1IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Oncogene Proteins (Oncogene Protein)IBA 01/2023
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	LDL CholesterolIBA 01/2023
1	AcidsIBA 11/2022
1	mannosamine (D-mannosamine)IBA 11/2022
1	N-acetyllactosamineIBA 11/2022
1	N-(3-acetamidopropyl)pyrrolidin-2-oneIBA 11/2022
1	Small Interfering RNA (siRNA)IBA 08/2022
1	UbiquitinIBA 08/2022
1	MicroRNAs (MicroRNA)IBA 08/2022
1	HydrolasesIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Epoxide HydrolasesIBA 01/2022
1	Carboxylesterase (Hydrolase S)IBA 01/2022
1	ProdrugsIBA 01/2022
1	Apoptosis Regulatory ProteinsIBA 01/2022
1	Thyroid Nuclear Factor 1IBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Rapeseed OilIBA 01/2021
1	CarcinogensIBA 01/2021
1	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2021
1	Corn Oil (Oil, Corn)IBA 01/2021
1	Leucovorin (Folinic Acid)FDA Link 11/2020
1	Fluorouracil (Carac)FDA LinkGeneric 11/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020
1	folfirinoxIBA 11/2020
1	Conditioned Culture MediaIBA 05/2020
1	Immunoglobulins (Immunoglobulin)IBA 02/2020
1	Recombinant ProteinsIBA 02/2020
1	Peptides (Polypeptides)IBA 02/2020
1	SphingolipidsIBA 01/2020
1	SphingomyelinsIBA 01/2020
1	2- (2'- (5- ethyl- 3,4- diphenyl- 1H- pyrazol- 1- yl)biphenyl- 3- yloxy)acetic acidIBA 01/2020
1	VaccinesIBA 01/2020
1	Estrogen ReceptorsIBA 01/2020

Therapy/Procedure

12	Therapeutics 01/2024 - 01/2013
1	Adjuvant Chemotherapy 02/2024
1	Neoadjuvant Therapy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 11/2020